A drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommended by the National Institute for Health and Care Excellence (NICE) to prevent episodic and chronic migraine attacks. The drug would be recommended to people who have at least four migraine days a month or where at least three previous preventative treatments have failed.
This article was originally published on MedicalXpress.com
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
© 2024 SimplyWell.ca